Lonsurf 15 MG-6.14 MG tablet 40S
Ended Awarded
- Contract number
- SPE2DR26F9BU8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,600
Award facts
- Contract value 100% obligated
- $21,600.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $21.6K to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Lonsurf (15 mg-6.14 mg tablets, 40-count packaging) with a completion date of December 9, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion vehicle designated SPE2DX that extends through December 2026 and serves as the company's primary mechanism for supplying pharmaceutical products and medical supplies to military healthcare systems globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a comprehensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company has demonstrated substantial capacity to fulfill federal medical supply needs through numerous competitive awards with the Defense Logistics Agency, ranging from small-value transactions to orders exceeding $45K. Lonsurf, a combination chemotherapy medication used in cancer treatment, represents the type of specialized pharmaceutical commodity the vendor routinely delivers to support military healthcare programs and other federal government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9BU8?
SPE2DR26F9BU8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26F9BU8 worth?
The government has obligated $21,600 on SPE2DR26F9BU8.
Is contract SPE2DR26F9BU8 an order under another contract?
Yes. SPE2DR26F9BU8 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9BU8 competed?
The extent of competition for SPE2DR26F9BU8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award